Acute Pancreatitis in Children With Acute Lymphoblastic Leukemia After Chemotherapy
Authors:
- Suporn TreepongkarunaSTSuporn Treepongkaruna
- Naporn ThongpakNTNaporn Thongpak
- Samart PakakasamaSPSamart Pakakasama
- Paneeya PienvichitPPPaneeya Pienvichit
- Nongnuch SirachainanNSNongnuch Sirachainan
- Suradej HongengSHSuradej Hongeng
- 1 November 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 31 (11) , 812-815
Abstract
Acute pancreatitis (AP) is a complication in children with acute lymphoblastic leukemia (ALL) receiving chemotherapy and has often been reported associated with L-asparaginase (L-asp) therapy. To determine the incidence, risk factors, clinical data, outcome, and mortality of AP in children with ALL. Retrospective cohort study was conducted by reviewing the data of total 192 pediatric ALL patients from Pediatric Oncology Registry at Ramathibodi Hospital from 2000 to 2006 to assess incidence, clinical data, outcome, and mortality of AP. Then, a nested case-control study was conducted to identify potential risk factors for AP by recruiting all patients with AP as cases (n=16), and randomly selected patients without AP to serve as controls up to approximately four controls per case with the total of 68 controls. The total incidence of AP in children with ALL and L-asp-associated AP was 8.3% and 7.3%, respectively. In patients with L-asp-associated AP, pancreatitis developed after the median 5.5 doses (range: 1 to 20 doses) of L-asp therapy and the median interval from the last dose of L-asp to the onset of AP was 4 days (range: 1 to 13 days). The mortality rate of AP group was significantly higher than the patients without AP (43.8% vs. 19.3%, P=0.02). Mortality was associated with concurrent systemic infection and complications of underlying diseases. Multivariate analysis identified using a high-risk chemotherapy regimen was the only risk factor for AP. Using a high-risk chemotherapy regimen was a risk factor for pancreatitis in patients with ALL. ALL children with AP had higher mortality rate than those without pancreatitis.Keywords
This publication has 22 references indexed in Scilit:
- Etiology and Outcome of Acute Pancreatitis in Infants and ToddlersThe Journal of Pediatrics, 2008
- Predicting asparaginase‐associated pancreatitisPediatric Blood & Cancer, 2006
- Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresisPediatric Blood & Cancer, 2006
- Drug-Induced PancreatitisJournal of Clinical Gastroenterology, 2005
- Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalBlood, 2004
- Acute Pancreatitis in ChildhoodJournal of Clinical Gastroenterology, 2003
- A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group studyBlood, 2002
- Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysisBone Marrow Transplantation, 1997
- Influence of severe underlying pathology and hypovolemic shock on the development of acute pancreatitis in childrenJournal of Pediatric Surgery, 1996
- Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemiaJournal of Pediatric Surgery, 1985